Endoxifen, a low-dose investigational drug, reduces breast density by up to 26%—matching tamoxifen effectiveness—while causing fewer side effects.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Low-dose drug cuts breast density up to 26% with fewer side effects
Up To 26% % Breast density reduction
Matches Tamoxifen Effectiveness comparison
Significantly Reduced Side effect profile
Fewer Adverse Effects side effect reduction
26% breast density reduction